Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
3rd Surgical Clinic of the University hospital 'ATTIKON', Rimini 1, 12462, Haidari, Greece. costfot@yahoo.gr
Colorectal cancer is the third most common form of cancer. Current treatments are all associated with a high risk of complications and a low success rate. Recently, synbiotics have been proposed as a new preventive and therapeutic option. There is no direct experimental evidence for cancer suppression in humans as a result of the consumption of pro-, pre- or synbiotics. However, there is a wealth of evidence emerging from laboratory studies. The mechanisms by which pro-, pre- and synbiotics may inhibit colon cancer are now beginning to be understood and will be addressed in the present review.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on